Adlai Nortye Ltd..
ANL.US | Research and experimental development on natural sciences and engineering
Adlai Nortye Ltd. is a biotechnology company focused on discovering and developing innovative therapies for cancer and other diseases. The company's pipeline includes several drug candidates in various stages of clinical development, targeting different types of cancer. Adlai Nortye partners with ot...Show More
Better Health for All
0
The provided article does not contain specific, quantitative data points for any of the 'Better Health for All' KPIs. It explicitly states that no data is available for metrics such as net health effect, harmful revenue share, safety record, pricing, access for vulnerable populations, risk transparency, health innovation investment, health externalities, health equity programs, healthcare workforce support, preventative health measures, healthcare data responsibility, global health crisis response, mental health initiatives, pharma patent flexibility, healthcare education, addiction mitigation, or clinical trial ethics.
1
Therefore, no KPIs can be scored based on the evidence provided.
Fair Money & Economic Opportunity
0
No evidence available to assess Adlai Nortye Ltd. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect. The articles explicitly state that data on living wage coverage, CEO median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, and health insurance coverage is not applicable or unavailable.
1
Fair Trade & Ethical Sourcing
0
No specific data or quantifiable metrics regarding Adlai Nortye Ltd.'s fair trade and ethical sourcing practices are provided in the available articles. There is no evidence for fair trade certification share, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, materials risk index, or supplier diversity spend.
1
The articles focus on corporate agreements, clinical pipeline, and general industry trends, without offering company-specific evidence for these KPIs.
Honest & Fair Business
10
The company's financial statements for 2021, 2022, and 2023 were 100% audited by Mazars USA LLP.
1
There have been zero financial restatements in the past five years.
2
The Audit Committee Charter, adopted April 21, 2023, mandates that all committee members are independent directors as defined by Nasdaq and SEC rules, and at least one member must be an audit committee financial expert.
3
The company has a whistleblower policy that encourages employees to report violations and strictly prohibits retaliation against those who report in good faith.
4
Procedures are established for confidential, anonymous submission of concerns regarding accounting, internal controls, or auditing matters to the Audit Committee.
5
The Code of Business Conduct and Ethics prohibits bribes and kickbacks and mentions compliance with the U.S. Foreign Corrupt Practices Act (FCPA).
6
However, the policy lacks customization for high-risk areas and there is no evidence of regular third-party audits of the anti-corruption program. The company has multiple independent directors, including Roger Sawhney, Shaorong Liu, Ming Lun Alan Tse, and Baozhong Wei, with Mr. Wei and Dr. Sawhney being appointed or re-designated as independent directors effective July 1, 2025.
7
The Audit Committee reviews disclosures made by the CEO and CFO during their certification process for Form 20-F concerning internal control deficiencies, fraud, and changes in internal controls.
8
The company also includes opinions from multiple law firms and its independent public accounting firm in its SEC filings.
9
Kind to Animals
-40
The company conducts pre-clinical studies of its drugs on animals to assess product safety, explicitly stating in a report that it exploits animals for product testing.
1
An example includes a study on mice transfected with FaDu cells to test AN2025.
2
No War, No Weapons
0
The provided article for Adlai Nortye (ANL.US) is an overview of the company's oncology focus, pipeline, research, and leadership.
1
It explicitly states that no data relevant to the company's involvement in arms or defense contracts, peacebuilding, conflict divestment, or any other metrics related to the 'No War, No Weapons' value are present.
2
Consequently, no quantitative or qualitative evidence could be found to score any of the KPIs in the rubric.
3
Planet-Friendly Business
0
No data relevant to the requested metrics for a planet-friendly business was found in the provided article.
1
The article focuses on company announcements, awards, personnel changes, clinical trials, and pipeline, without addressing environmental or social impact metrics.
2
Respect for Cultures & Communities
0
No evidence was found in the provided article to assess ANL.US against any of the KPIs for the 'Respect for Cultures & Communities' ethical value.
1
The article is a job posting and does not contain relevant data.
2
Safe & Smart Tech
0
No evidence available to assess Adlai Nortye Ltd. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess Adlai Nortye Ltd. on Zero Waste & Sustainable Products.